$1,000 invested Merck & Co. Inc. (2023)
NYSE · MRK · reinvest dividends · adjusted close
●Result2023-01-03 — 2026-10-15
Today you would have
$1,442
+$442 (+44.20%)
MRKSPY (benchmark)
- Entry price
- $100.68
- Current price
- $145.19
- Shares
- 9.9321
- CAGR
- +10.17%
- Max Drawdown
- -43.44%
- vs SPY
- -67.20 pp
✦The story
$1,000 invested in Merck at the start of 2023 was worth $1,442 by mid-2026, a return of +44.2%. The pharmaceutical company continued to rely on its blockbuster cancer drug Keytruda while investors weighed questions about future growth. The stock lagged the S&P 500, which returned +111.4% over the same period.
#Related scenariosfor comparison
Other years for MRK